Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$86.23 - $125.19 $877,476 - $1.27 Million
-10,176 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $628,451 - $884,848
7,938 Added 354.69%
10,176 $912,000
Q3 2020

Nov 16, 2020

BUY
$81.91 - $134.94 $183,314 - $301,995
2,238 New
2,238 $231,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $412M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.